These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 20202594

  • 1. B-cell biology and related therapies in systemic lupus erythematosus.
    Ahmed S, Anolik JH.
    Rheum Dis Clin North Am; 2010 Feb; 36(1):109-30, viii-ix. PubMed ID: 20202594
    [Abstract] [Full Text] [Related]

  • 2. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R, Anolik JH.
    Drugs; 2006 Feb; 66(15):1933-48. PubMed ID: 17100405
    [Abstract] [Full Text] [Related]

  • 3. B cell biology: implications for treatment of systemic lupus erythematosus.
    Anolik JH.
    Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
    [Abstract] [Full Text] [Related]

  • 4. B cell biology and dysfunction in SLE.
    Anolik JH.
    Bull NYU Hosp Jt Dis; 2007 Apr; 65(3):182-6. PubMed ID: 17922667
    [Abstract] [Full Text] [Related]

  • 5. B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells.
    Looney RJ, Anolik J, Sanz I.
    Lupus; 2004 Apr; 13(5):381-90. PubMed ID: 15230297
    [Abstract] [Full Text] [Related]

  • 6. Treatment targets in systemic lupus erythematosus: biology and clinical perspective.
    Marian V, Anolik JH.
    Arthritis Res Ther; 2012 Apr; 14 Suppl 4(Suppl 4):S3. PubMed ID: 23281796
    [Abstract] [Full Text] [Related]

  • 7. Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20).
    Eisenberg R.
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):345-50. PubMed ID: 17214580
    [Abstract] [Full Text] [Related]

  • 8. [B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].
    Tanaka Y.
    Yakugaku Zasshi; 2009 Jun; 129(6):675-9. PubMed ID: 19483410
    [Abstract] [Full Text] [Related]

  • 9. Targeted B-cell depletion therapy in childhood-onset systemic lupus erythematosus: progress to date.
    Marks SD, Tullus K.
    Paediatr Drugs; 2007 Jun; 9(6):371-8. PubMed ID: 18052407
    [Abstract] [Full Text] [Related]

  • 10. Treatment of inflammatory immunologic disease 4. B cell targeting therapy using the anti-CD20 antibody rituximab in inflammatory autoimmune diseases.
    Tanaka Y.
    Intern Med; 2007 Jun; 46(16):1313-5. PubMed ID: 17704614
    [No Abstract] [Full Text] [Related]

  • 11. Targeting B cells with biologics in systemic lupus erythematosus.
    La Cava A.
    Expert Opin Biol Ther; 2010 Nov; 10(11):1555-61. PubMed ID: 20919800
    [Abstract] [Full Text] [Related]

  • 12. The biology behind the new therapies for SLE.
    Ermann J, Bermas BL.
    Int J Clin Pract; 2007 Dec; 61(12):2113-9. PubMed ID: 17997810
    [Abstract] [Full Text] [Related]

  • 13. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F, Isenberg DA.
    Handb Exp Pharmacol; 2008 Dec; (181):163-81. PubMed ID: 18071946
    [Abstract] [Full Text] [Related]

  • 14. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.
    Harvey PR, Gordon C.
    BioDrugs; 2013 Apr; 27(2):85-95. PubMed ID: 23456653
    [Abstract] [Full Text] [Related]

  • 15. The pathological role of B cells in systemic lupus erythematosus: From basic research to clinical.
    Feng Y, Yang M, Wu H, Lu Q.
    Autoimmunity; 2020 Mar; 53(2):56-64. PubMed ID: 31876195
    [Abstract] [Full Text] [Related]

  • 16. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity.
    Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F.
    Cytokine Growth Factor Rev; 2013 Jun; 24(3):203-15. PubMed ID: 23684423
    [Abstract] [Full Text] [Related]

  • 17. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R, Albert D.
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [Abstract] [Full Text] [Related]

  • 18. Treatment of SLE with anti-CD20 monoclonal antibody.
    Looney RJ, Anolik J, Sanz I.
    Curr Dir Autoimmun; 2005 Jan; 8():193-205. PubMed ID: 15564722
    [Abstract] [Full Text] [Related]

  • 19. Connective tissue diseases: The conundrum of B cell depletion in SLE.
    Sanz I.
    Nat Rev Rheumatol; 2009 Jun; 5(6):304-5. PubMed ID: 19491910
    [Abstract] [Full Text] [Related]

  • 20. Rituximab: a promising therapy in systemic lupus erythematosus.
    Thatayatikom A, White AJ.
    Autoimmun Rev; 2006 Jan; 5(1):18-24. PubMed ID: 16338207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.